The results of KEGG pathway enrichment analysis is supported by the results of drug association analysis, which showed that potential therapeutic target of brazilin against metastatic breast cancer cells (PB) are associated with tyrosine kinase inhibitors and TNFα inhibitors (Supplementary Table 6). Here, TNF is linked to breast cancer.